EUVIMEDEUVIMED entdecken
Crossref

A Novel Trained Immunity Adjuvant Derived From Commensal Bacteria Potentiates Liposome–Hydrogel Cancer Vaccine Against Breast Tumors

Cheng-Kai Zhou, Jian-Gang Zhang, Zi-Ran Peng, Xue-Yue Luo, Liang Zhang, Tie-Lin Wang, Wei-Qiang Wan, Han-Xi Yang, Wei Chen, Yong-Jun Yang iD

Advanced Healthcare Materials · 2026-03 · 15 (12)

DOI: 10.1002/adhm.202504705 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 29.12.2025. Verfasst von Cheng-Kai Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Liposomes, Cancer Vaccines, Hydrogels, Adjuvants, Immunologic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traditionally, vaccines rely on adaptive immunity to confer protection, yet emerging evidence highlights the importance of trained immunity in enhancing innate immune responses for broad‐spectrum defense. The M28 family peptidase (M28), secreted by the commensal bacterium Peribacillus frigoritolerans , acts as a novel inducer of trained immunity with adjuvant potential. In studies using ovalbumin (OVA) as model antigen, both free M28 and M28‐loaded liposome (M28‐Lipo) significantly enhanced antigen‐specific IgG production, stimulated splenic CD4 + /CD8 + T cell proliferation, and induced balanced Th1/Th2 immunity, with M28‐Lipo demonstrating superior efficacy. Building on these findings, a biphasic‐release breast cancer vaccine (Zfp142‐Lipo + M28@ sodium alginate (ALG)) was developed by co‐delivering the tumor‐specific neoantigen Zfp142 and M28 using a hydrogel‐liposome hybrid system. This formulation enabled sustained antigen release and targeted accumulation in lymph nodes and tumor tissues. Prophylactic administration completely inhibited 4T1 tumorigenesis and pulmonary metastasis, whereas therapeutic administration significantly suppressed tumor progression and dissemination. Mechanistic analysis revealed enhanced infiltration of CD4⁺ and CD8⁺ T cells, reduction of regulatory T cells, and M2‐to‐M1 macrophage repolarization within the tumor microenvironment. These findings establish M28 as a safe and potent adjuvant that reprograms the tumor microenvironment and effectively bridges innate and adaptive immunity, providing a versatile platform for cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesCancer VaccinesHydrogelsAdjuvants, ImmunologicBreast NeoplasmsAnimalsFemaleMiceMice, Inbred BALB CCell Line, TumorCD8-Positive T-LymphocytesTrained Immunity

Stichwörter der Autor:innen

M28 family peptidaseadjuvantbreast tumor nanovaccinemicroenvironmenttrained immunity

Substanzen

LiposomesCancer VaccinesHydrogelsAdjuvants, Immunologic

Autor:innen und Institutionen

  • Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, China.
  • Hospital for Skin Diseases, Shandong First Medical University, Jinan, China.
  • School of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Animal Disease Prevention and Control Center, Xishuangbanna, China.

ORCID-Profile: Yong-Jun Yang

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Zhou, C. K., Zhang, J. G., Peng, Z. R., Luo, X. Y., Zhang, L., Wang, T. L., Wan, W. Q., Yang, H. X., Chen, W., & Yang, Y. J. (2026). A Novel Trained Immunity Adjuvant Derived From Commensal Bacteria Potentiates Liposome–Hydrogel Cancer Vaccine Against Breast Tumors. Advanced Healthcare Materials, 15(12). https://doi.org/10.1002/adhm.202504705

Vancouver

Zhou CK, Zhang JG, Peng ZR, Luo XY, Zhang L, Wang TL, et al. A Novel Trained Immunity Adjuvant Derived From Commensal Bacteria Potentiates Liposome–Hydrogel Cancer Vaccine Against Breast Tumors. Advanced Healthcare Materials. 2026;15(12). doi:10.1002/adhm.202504705

BibTeX
@article{Zhou2026,
  author = {Zhou, Cheng-Kai and Zhang, Jian-Gang and Peng, Zi-Ran and Luo, Xue-Yue and Zhang, Liang and Wang, Tie-Lin and Wan, Wei-Qiang and Yang, Han-Xi and Chen, Wei and Yang, Yong-Jun},
  title = {A Novel Trained Immunity Adjuvant Derived From Commensal Bacteria Potentiates Liposome–Hydrogel Cancer Vaccine Against Breast Tumors},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {12},
  doi = {10.1002/adhm.202504705}
}
Kostenlos starten →